查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
嗜睡症治療全球市場規模、份額和行業趨勢分析報告：2022-2028 年按類型、產品和地區劃分的展望和預測
市場調查報告書
商品編碼
1126871

嗜睡症治療全球市場規模、份額和行業趨勢分析報告：2022-2028 年按類型、產品和地區劃分的展望和預測

Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 170 Pages | 訂單完成後即時交付

價格

到 2028 年，全球嗜睡症藥物市場規模預計將達到 50 億美元，在預測期內以 10.5% 的複合年增長率增長。

最近在歐盟和美國批准用於治療與發作性睡病相關的 EDS 的藥物是多巴胺和去甲腎上腺素再攝取抑製劑 soliumfetol 和 H3R 拮抗劑pitrizant。許多新藥已被開發和測試用於治療與 EDS 和發作性睡病相關的猝倒，包括新型羥丁酸鹽低鈉製劑（FT218）、過夜製劑（JZP-258）和選擇性去甲腎上腺素再攝取抑製劑（AXS- 12）、莫達非尼和星形□□膠質細胞連接蛋白抑製劑（THN102）。

最近批准和研究的用於發作性睡病的藥物的作用機制、藥代動力學、療效、安全性/耐受性。嗜睡症是一種與過度嗜睡相關的慢性神經系統疾病，據認為全世界每 100,000 人中有 20-67 人患有嗜睡症。嗜睡症通常在二十多歲時開始，但通常在很晚才被診斷出來。

白天過度嗜睡 (EDS) 不是發作性睡病獨有的症狀，但應該在每個人身上看到以進行診斷。超過 60% 的患者有猝倒症。猝倒是清醒時肌肉張力的不自覺降低，通常由強烈的情緒引發。其他症狀包括不安的夜晚、入睡和醒來時的催眠和催眠幻覺，以及睡眠麻痺。

COVID-19 影響分析

在大流行期間，COVID-19 對嗜睡症藥物產生了負面影響。最大的問題是發作性睡病患者停止服藥，因為由於交通限制、家庭隔離和擔心醫院交叉感染，他們無法開出處方。此外，由於沒有針對 COVID-19 的有效治療方法，製造商和公司正在加大力度生產治療 COVID-19 所需的藥物和工具。

市場增長因素

醫療保健支出增加

推動市場增長的主要因素之一是政府對醫療保健行業的投資數量和規模不斷增加。這是因為由於發展中國家經濟的快速發展和醫療費用的上漲，高質量醫療保健的可及性預計將進一步擴大。這被視為嗜睡症藥物行業擴張的積極指標。由於這些國家的失眠問題日益嚴重，對各種治療方法和設備的需求猛增。

神經系統疾病的患病率增加

神經科醫生治療各種睡眠問題，包括發作性睡病、睡眠呼吸暫停、不寧腿綜合徵、失眠和睡眠呼吸暫停。內在的不規則是由幾種疾病引起的，會破壞規律的睡眠-覺醒週期。在接下來的幾年裡，隨著很大一部分人口老齡化，與神經睡眠相關的疾病預計會增加。美國國立衛生研究院 (NIH) 估計有 2000 萬美國人不時有睡眠問題，而估計有 4000 萬美國人患有神經系統疾病。

市場製約因素

診斷和治療嗜睡症的高昂費用

抑制嗜睡症市場的主要因素之一是嗜睡症診斷和治療的高成本。此外，“睡眠問題”一詞是指對個人健康產生嚴重不利影響並帶來巨大社會成本的一系列疾病。此外，2019年，嗜睡症市場的平穩運行將受到高額治療費用的阻礙。嗜睡症會擾亂日常功能，而且還會帶來巨大的經濟和醫療負擔——許多患者完全殘疾。

按類型劃分的前景

嗜睡症藥物市場按類型分為帶 cataplekey 的發作性睡病、不帶 cataplekey 的發作性睡病和繼發性發作性睡病。發作性睡病伴猝倒症細分市場將在 2021 年獲得發作性睡病治療市場最高的收入份額。這是因為猝倒症正在成為患者中更為常見和重要的症狀。預計在整個預測期間將保持其位置。

產品展望

根據產品，嗜睡症治療市場分為中樞神經系統興奮劑、羥丁酸鈉、選擇性血清素再攝取抑製劑、三環類抗抑鬱藥等。到 2021 年，中樞神經系統興奮劑部門將在嗜睡症治療市場中獲得可觀的收入份額。中樞神經系統藥物的數據分析，以評估成人發作性睡病患者對 Pitrisant 對白天過度嗜睡 (EDS) 和猝倒的反應開始時間。

區域展望

按地區分析了北美、歐洲、亞太地區和 LAMEA 的嗜睡症藥物市場。到 2021 年，亞太地區將在嗜睡症治療市場中獲得可觀的收入份額。這是由於經濟增長、公眾意識提高、可支配收入高、製藥和生物技術行業投資增加以及政府的慈善努力。在亞太國家中，日本被指出為嗜睡症的高發國家。

內容

第一章市場範圍和研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球嗜睡症藥物市場（按類型）
    • 全球嗜睡症藥物市場，按產品分類
    • 全球嗜睡症藥物市場，按地區分列
  • 調查方法

第 2 章市場概述

  • 簡介
    • 簡介
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動力
    • 市場製約因素

第 3 章。全球嗜睡症藥物市場：按類型分類

  • 全球發作性睡病伴猝倒症市場：按地區劃分
  • 無猝倒症的嗜睡症的全球市場：按地區劃分
  • 全球繼發性嗜睡症市場：按地區

第 4 章. 嗜睡症藥物的全球市場，副產品

  • 世界羥丁酸鈉市場：按地區
  • 按地區分列的選擇性血清素再攝取抑製劑全球市場
  • 按地區分列的中樞神經系統興奮劑全球市場
  • 按地區分列的全球三環類抗抑鬱藥市場
  • 世界其他地區的世界市場

第 5 章。全球嗜睡症藥物市場：按地區劃分

  • 北美
    • 北美嗜睡症藥物市場：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
      • 北美以外的地區
  • 歐洲
    • 歐洲嗜睡症藥物市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太嗜睡症治療市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • LAMEA
    • LAMEA 嗜睡症藥物市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • LAMEA 其他地區

第 6 章公司簡介

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.（Arena Pharmaceuticals, Inc.）
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

The Global Narcolepsy Therapeutics Market size is expected to reach $5 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period.

Chronic, incapacitating neurologic disease called narcolepsy is characterized by excessive daytime sleepiness (EDS). Modafinil, armodafinil, and stimulants are only a few of the medications used to treat narcolepsy. Others include sodium oxybate and venlafaxine, which are used to treat the symptoms of sleep paralysis and sleep-related hallucinations (e.g. sodium oxybate).

In general, drugs that boost norepinephrine or dopamine release or prevent their reuptake have wake-promoting effects and can help manage EDS, whereas drugs that block serotonin or norepinephrine reuptake have anti-cataplexy benefits. Both EDS and cataplexy are affected by the modification of either histamine H3 receptors (H3Rs) or -aminobutyric acid B (GABAB) receptors.

The most recent approved medications for EDS related to narcolepsy in the European Union and the USA are solriamfetol, a dopamine and norepinephrine reuptake inhibitor, and pitolisant, an H3R antagonist. Many new drugs are being developed and tested as potential treatments for EDS and cataplexy associated with narcolepsy (THN102), including novel Oxybate formulations of low sodium [FT218] and one-nightly [JZP-258], selective norepinephrine reuptake inhibitors (AXS-12), and modafinil and astroglial connexin inhibitors (THN102).

The mechanisms of action, pharmacokinetics, effectiveness, and safety/tolerability of recently authorized and developing therapies for narcolepsy. A chronic, incapacitating neurologic condition of hypersomnolence called narcolepsy is thought to affect 20-67 persons per 100,000 people across the world. Narcolepsy typically begins in the second decade of life; however, a diagnosis is frequently made much later.

Excessive daytime sleepiness (EDS), while not a specific symptom of narcolepsy, is a feature of the illness that must be present in all individuals to make the diagnosis. Up to 60% of patients have cataplexy, an involuntary decrease of muscle tone while awake that is generally brought on by intense emotions. Restless nights, hypnagogic and hypnopompic hallucinations that happen when the user falls asleep and wakes up, and sleep paralysis are other symptoms.

COVID-19 Impact Analysis

During the pandemic, COVID-19 had a detrimental effect on narcolepsy medications. The biggest problem is that patients with narcolepsy can stop taking their medication because they are unable to get their prescriptions filled because of transportation limitations, home quarantines, and hospital cross-infection fears. Additionally, because there is no effective treatment for COVID-19, manufacturers and companies are concentrating more on producing the pharmaceuticals and tools that are required for treating COVID-19.  

Market Growth Factors

Growing Healthcare Expenditures

One of the main factors boosting the market's rise is the rising number and size of investments made in the healthcare sector by governments of various countries. It is anticipated that more developing nations would have greater access to high-quality healthcare as a result of their quick economic development and growing healthcare costs. This is viewed as a positive indicator of expansion for the narcolepsy therapeutics industry. The need for various treatment and apparatus has surged in these nations due to the rising insomnia problems.

Increasing Prevalence Of Neurological Conditions

Neurologists treat a wide variety of sleep problems, including narcolepsy, sleep apnea, restless legs syndrome, insomnia, and sleep apnea. Endogenous irregularities are brought on by several illnesses, which interfere with the regular sleep-wake cycle. In the upcoming years, neurological sleep-related diseases are predicted to rise as a significant section of the population ages. The National Institute of Health (NIH) estimates that 20 million Americans occasionally have sleep issues, whereas 40 million Americans suffer from neurological illnesses.

Market Restraining Factors

High Cost Of Narcolepsy Diagnosis & Treatment

One of the main factors holding back the narcolepsy market is the high cost of narcolepsy diagnosis and treatment. Additionally, the term "sleeping problem" refers to a broad range of illnesses with serious negative effects on the health of the individual and huge societal costs. Furthermore, in 2019 the smooth operation of the narcolepsy market is disrupted by the high cost of therapy. Daily functioning is hampered by narcolepsy, which is also connected with a significant financial and medical burden-many patients are fully disabled.

Type Outlook

On the basis of Type, the Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. The Narcolepsy with Cataplexy segment acquired the highest revenue share in the narcolepsy therapeutics market in 2021. It is because cataplexy is becoming a more common significant symptom among patients. Throughout the prediction, it is anticipated to hold onto its position.

Product Outlook

Based on the Product, the Narcolepsy Therapeutics Market is divided into Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake inhibitors, Tricyclic Antidepressants, and Others. The Central Nervous System Stimulants segment recorded a substantial revenue share in the narcolepsy therapeutics market in 2021. It is because the data analysis of CNS Drugs assesses the time to onset of response to pitolisant for excessive daytime sleepiness (EDS) and cataplexy in adult narcolepsy patients.

Regional Outlook

Region-wise, the Narcolepsy Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a promising revenue share in the narcolepsy therapeutics market in 2021. It is due to economic growth, a rise in public awareness, high levels of disposable money, a rise in investments in the pharmaceutical and biotechnology industries, and benevolent government efforts. Among the Asia Pacific nations, Japan has been noted as having a high prevalence of narcolepsy.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Narcolepsy with Cataplexy
  • Narcolepsy Without Cataplexy
  • Secondary Narcolepsy

By Product

  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Narcolepsy Therapeutics Market, by Type
    • 1.4.2 Global Narcolepsy Therapeutics Market, by Product
    • 1.4.3 Global Narcolepsy Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Narcolepsy Therapeutics Market by Type

  • 3.1 Global Narcolepsy with Cataplexy Market by Region
  • 3.2 Global Narcolepsy Without Cataplexy Market by Region
  • 3.3 Global Secondary Narcolepsy Market by Region

Chapter 4. Global Narcolepsy Therapeutics Market by Product

  • 4.1 Global Sodium Oxybate Market by Region
  • 4.2 Global Selective Serotonin Reuptake Inhibitor Market by Region
  • 4.3 Global Central Nervous System Stimulants Market by Region
  • 4.4 Global Tricyclic Antidepressants Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global Narcolepsy Therapeutics Market by Region

  • 5.1 North America Narcolepsy Therapeutics Market
    • 5.1.1 North America Narcolepsy Therapeutics Market by Type
      • 5.1.1.1 North America Narcolepsy with Cataplexy Market by Country
      • 5.1.1.2 North America Narcolepsy Without Cataplexy Market by Country
      • 5.1.1.3 North America Secondary Narcolepsy Market by Country
    • 5.1.2 North America Narcolepsy Therapeutics Market by Product
      • 5.1.2.1 North America Sodium Oxybate Market by Country
      • 5.1.2.2 North America Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.1.2.3 North America Central Nervous System Stimulants Market by Country
      • 5.1.2.4 North America Tricyclic Antidepressants Market by Country
      • 5.1.2.5 North America Others Market by Country
    • 5.1.3 North America Narcolepsy Therapeutics Market by Country
      • 5.1.3.1 US Narcolepsy Therapeutics Market
        • 5.1.3.1.1 US Narcolepsy Therapeutics Market by Type
        • 5.1.3.1.2 US Narcolepsy Therapeutics Market by Product
      • 5.1.3.2 Canada Narcolepsy Therapeutics Market
        • 5.1.3.2.1 Canada Narcolepsy Therapeutics Market by Type
        • 5.1.3.2.2 Canada Narcolepsy Therapeutics Market by Product
      • 5.1.3.3 Mexico Narcolepsy Therapeutics Market
        • 5.1.3.3.1 Mexico Narcolepsy Therapeutics Market by Type
        • 5.1.3.3.2 Mexico Narcolepsy Therapeutics Market by Product
      • 5.1.3.4 Rest of North America Narcolepsy Therapeutics Market
        • 5.1.3.4.1 Rest of North America Narcolepsy Therapeutics Market by Type
        • 5.1.3.4.2 Rest of North America Narcolepsy Therapeutics Market by Product
  • 5.2 Europe Narcolepsy Therapeutics Market
    • 5.2.1 Europe Narcolepsy Therapeutics Market by Type
      • 5.2.1.1 Europe Narcolepsy with Cataplexy Market by Country
      • 5.2.1.2 Europe Narcolepsy Without Cataplexy Market by Country
      • 5.2.1.3 Europe Secondary Narcolepsy Market by Country
    • 5.2.2 Europe Narcolepsy Therapeutics Market by Product
      • 5.2.2.1 Europe Sodium Oxybate Market by Country
      • 5.2.2.2 Europe Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.2.2.3 Europe Central Nervous System Stimulants Market by Country
      • 5.2.2.4 Europe Tricyclic Antidepressants Market by Country
      • 5.2.2.5 Europe Others Market by Country
    • 5.2.3 Europe Narcolepsy Therapeutics Market by Country
      • 5.2.3.1 Germany Narcolepsy Therapeutics Market
        • 5.2.3.1.1 Germany Narcolepsy Therapeutics Market by Type
        • 5.2.3.1.2 Germany Narcolepsy Therapeutics Market by Product
      • 5.2.3.2 UK Narcolepsy Therapeutics Market
        • 5.2.3.2.1 UK Narcolepsy Therapeutics Market by Type
        • 5.2.3.2.2 UK Narcolepsy Therapeutics Market by Product
      • 5.2.3.3 France Narcolepsy Therapeutics Market
        • 5.2.3.3.1 France Narcolepsy Therapeutics Market by Type
        • 5.2.3.3.2 France Narcolepsy Therapeutics Market by Product
      • 5.2.3.4 Russia Narcolepsy Therapeutics Market
        • 5.2.3.4.1 Russia Narcolepsy Therapeutics Market by Type
        • 5.2.3.4.2 Russia Narcolepsy Therapeutics Market by Product
      • 5.2.3.5 Spain Narcolepsy Therapeutics Market
        • 5.2.3.5.1 Spain Narcolepsy Therapeutics Market by Type
        • 5.2.3.5.2 Spain Narcolepsy Therapeutics Market by Product
      • 5.2.3.6 Italy Narcolepsy Therapeutics Market
        • 5.2.3.6.1 Italy Narcolepsy Therapeutics Market by Type
        • 5.2.3.6.2 Italy Narcolepsy Therapeutics Market by Product
      • 5.2.3.7 Rest of Europe Narcolepsy Therapeutics Market
        • 5.2.3.7.1 Rest of Europe Narcolepsy Therapeutics Market by Type
        • 5.2.3.7.2 Rest of Europe Narcolepsy Therapeutics Market by Product
  • 5.3 Asia Pacific Narcolepsy Therapeutics Market
    • 5.3.1 Asia Pacific Narcolepsy Therapeutics Market by Type
      • 5.3.1.1 Asia Pacific Narcolepsy with Cataplexy Market by Country
      • 5.3.1.2 Asia Pacific Narcolepsy Without Cataplexy Market by Country
      • 5.3.1.3 Asia Pacific Secondary Narcolepsy Market by Country
    • 5.3.2 Asia Pacific Narcolepsy Therapeutics Market by Product
      • 5.3.2.1 Asia Pacific Sodium Oxybate Market by Country
      • 5.3.2.2 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.3.2.3 Asia Pacific Central Nervous System Stimulants Market by Country
      • 5.3.2.4 Asia Pacific Tricyclic Antidepressants Market by Country
      • 5.3.2.5 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Narcolepsy Therapeutics Market by Country
      • 5.3.3.1 China Narcolepsy Therapeutics Market
        • 5.3.3.1.1 China Narcolepsy Therapeutics Market by Type
        • 5.3.3.1.2 China Narcolepsy Therapeutics Market by Product
      • 5.3.3.2 Japan Narcolepsy Therapeutics Market
        • 5.3.3.2.1 Japan Narcolepsy Therapeutics Market by Type
        • 5.3.3.2.2 Japan Narcolepsy Therapeutics Market by Product
      • 5.3.3.3 India Narcolepsy Therapeutics Market
        • 5.3.3.3.1 India Narcolepsy Therapeutics Market by Type
        • 5.3.3.3.2 India Narcolepsy Therapeutics Market by Product
      • 5.3.3.4 South Korea Narcolepsy Therapeutics Market
        • 5.3.3.4.1 South Korea Narcolepsy Therapeutics Market by Type
        • 5.3.3.4.2 South Korea Narcolepsy Therapeutics Market by Product
      • 5.3.3.5 Singapore Narcolepsy Therapeutics Market
        • 5.3.3.5.1 Singapore Narcolepsy Therapeutics Market by Type
        • 5.3.3.5.2 Singapore Narcolepsy Therapeutics Market by Product
      • 5.3.3.6 Malaysia Narcolepsy Therapeutics Market
        • 5.3.3.6.1 Malaysia Narcolepsy Therapeutics Market by Type
        • 5.3.3.6.2 Malaysia Narcolepsy Therapeutics Market by Product
      • 5.3.3.7 Rest of Asia Pacific Narcolepsy Therapeutics Market
        • 5.3.3.7.1 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type
        • 5.3.3.7.2 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product
  • 5.4 LAMEA Narcolepsy Therapeutics Market
    • 5.4.1 LAMEA Narcolepsy Therapeutics Market by Type
      • 5.4.1.1 LAMEA Narcolepsy with Cataplexy Market by Country
      • 5.4.1.2 LAMEA Narcolepsy Without Cataplexy Market by Country
      • 5.4.1.3 LAMEA Secondary Narcolepsy Market by Country
    • 5.4.2 LAMEA Narcolepsy Therapeutics Market by Product
      • 5.4.2.1 LAMEA Sodium Oxybate Market by Country
      • 5.4.2.2 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.4.2.3 LAMEA Central Nervous System Stimulants Market by Country
      • 5.4.2.4 LAMEA Tricyclic Antidepressants Market by Country
      • 5.4.2.5 LAMEA Others Market by Country
    • 5.4.3 LAMEA Narcolepsy Therapeutics Market by Country
      • 5.4.3.1 Brazil Narcolepsy Therapeutics Market
        • 5.4.3.1.1 Brazil Narcolepsy Therapeutics Market by Type
        • 5.4.3.1.2 Brazil Narcolepsy Therapeutics Market by Product
      • 5.4.3.2 Argentina Narcolepsy Therapeutics Market
        • 5.4.3.2.1 Argentina Narcolepsy Therapeutics Market by Type
        • 5.4.3.2.2 Argentina Narcolepsy Therapeutics Market by Product
      • 5.4.3.3 UAE Narcolepsy Therapeutics Market
        • 5.4.3.3.1 UAE Narcolepsy Therapeutics Market by Type
        • 5.4.3.3.2 UAE Narcolepsy Therapeutics Market by Product
      • 5.4.3.4 Saudi Arabia Narcolepsy Therapeutics Market
        • 5.4.3.4.1 Saudi Arabia Narcolepsy Therapeutics Market by Type
        • 5.4.3.4.2 Saudi Arabia Narcolepsy Therapeutics Market by Product
      • 5.4.3.5 South Africa Narcolepsy Therapeutics Market
        • 5.4.3.5.1 South Africa Narcolepsy Therapeutics Market by Type
        • 5.4.3.5.2 South Africa Narcolepsy Therapeutics Market by Product
      • 5.4.3.6 Nigeria Narcolepsy Therapeutics Market
        • 5.4.3.6.1 Nigeria Narcolepsy Therapeutics Market by Type
        • 5.4.3.6.2 Nigeria Narcolepsy Therapeutics Market by Product
      • 5.4.3.7 Rest of LAMEA Narcolepsy Therapeutics Market
        • 5.4.3.7.1 Rest of LAMEA Narcolepsy Therapeutics Market by Type
        • 5.4.3.7.2 Rest of LAMEA Narcolepsy Therapeutics Market by Product

Chapter 6. Company Profiles

  • 6.1 Jazz Pharmaceuticals plc
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional Analysis
    • 6.1.4 Research & Development Expenses
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Partnerships, Collaborations, and Agreements:
      • 6.1.5.2 Approvals and Trials:
  • 6.2 Shionogi & Co., Ltd.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Research & Development Expenses
  • 6.3 Teva Pharmaceutical Industries Ltd.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional Analysis
    • 6.3.4 Research & Development Expenses
  • 6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional & Segmental Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 Bioprojet
    • 6.5.1 Company Overview
    • 6.5.2 Recent strategies and developments:
      • 6.5.2.1 Partnerships, Collaborations, and Agreements:
  • 6.6 Takeda Pharmaceutical Company Limited
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Regional Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Ligand Pharmaceuticals, Inc.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Research & Development Expenses
  • 6.8 Graymark Healthcare, Inc.
    • 6.8.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Global Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Narcolepsy with Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Narcolepsy with Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Narcolepsy Without Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Narcolepsy Without Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Secondary Narcolepsy Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Secondary Narcolepsy Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 12 Global Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 13 Global Sodium Oxybate Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Sodium Oxybate Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Central Nervous System Stimulants Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Central Nervous System Stimulants Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Tricyclic Antidepressants Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Tricyclic Antidepressants Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Narcolepsy Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Narcolepsy Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 25 North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 26 North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 27 North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 28 North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 29 North America Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 36 North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 37 North America Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 49 US Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 50 US Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 51 US Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 52 US Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 53 US Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 54 US Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 55 Canada Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 56 Canada Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 57 Canada Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 58 Canada Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 59 Canada Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 60 Canada Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 61 Mexico Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 62 Mexico Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 63 Mexico Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 64 Mexico Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Mexico Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 66 Mexico Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 67 Rest of North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 68 Rest of North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 69 Rest of North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 70 Rest of North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 71 Rest of North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Rest of North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 74 Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 75 Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 76 Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 77 Europe Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 82 Europe Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 83 Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 84 Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 85 Europe Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 86 Europe Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 87 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 88 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 89 Europe Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Europe Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 92 Europe Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 93 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Germany Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 98 Germany Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 99 Germany Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 100 Germany Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 101 Germany Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Germany Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 103 UK Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 104 UK Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 105 UK Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 106 UK Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 107 UK Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 108 UK Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 109 France Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 110 France Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 111 France Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 112 France Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 113 France Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 France Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 Russia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 116 Russia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 117 Russia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 118 Russia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 119 Russia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 120 Russia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 121 Spain Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 122 Spain Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 123 Spain Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Spain Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 125 Spain Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 126 Spain Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 127 Italy Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 128 Italy Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 129 Italy Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Italy Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Italy Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 132 Italy Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 133 Rest of Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 134 Rest of Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 135 Rest of Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 136 Rest of Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 137 Rest of Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 138 Rest of Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 147 Asia Pacific Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Asia Pacific Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 150 Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 151 Asia Pacific Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Asia Pacific Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 155 Asia Pacific Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 156 Asia Pacific Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 157 Asia Pacific Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Asia Pacific Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Asia Pacific Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 162 Asia Pacific Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 163 China Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 164 China Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 165 China Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 166 China Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 167 China Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 168 China Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 169 Japan Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 170 Japan Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 171 Japan Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Japan Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Japan Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 174 Japan Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 175 India Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 176 India Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 177 India Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 178 India Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 179 India Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 180 India Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 181 South Korea Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 182 South Korea Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 183 South Korea Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 184 South Korea Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 185 South Korea Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 186 South Korea Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 187 Singapore Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 188 Singapore Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 189 Singapore Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Singapore Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Singapore Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 192 Singapore Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 193 Malaysia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 194 Malaysia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 195 Malaysia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 196 Malaysia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 197 Malaysia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 198 Malaysia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 199 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 200 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 201 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 202 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 203 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 204 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 205 LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 206 LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 209 LAMEA Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 210 LAMEA Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 211 LAMEA Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 LAMEA Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 LAMEA Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 214 LAMEA Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 215 LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 216 LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 217 LAMEA Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 218 LAMEA Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 219 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 220 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 221 LAMEA Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 222 LAMEA Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 223 LAMEA Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 224 LAMEA Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 225 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 226 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 227 LAMEA Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 228 LAMEA Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 229 Brazil Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 230 Brazil Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 231 Brazil Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 232 Brazil Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Brazil Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 234 Brazil Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 235 Argentina Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 236 Argentina Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 237 Argentina Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 238 Argentina Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 239 Argentina Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 240 Argentina Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 241 UAE Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 242 UAE Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 243 UAE Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 244 UAE Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 245 UAE Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 246 UAE Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 247 Saudi Arabia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 248 Saudi Arabia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 249 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 250 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 251 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 252 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 253 South Africa Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 254 South Africa Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 255 South Africa Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 256 South Africa Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 257 South Africa Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 258 South Africa Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 259 Nigeria Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 260 Nigeria Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 261 Nigeria Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 262 Nigeria Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 263 Nigeria Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 264 Nigeria Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 265 Rest of LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 266 Rest of LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 267 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 268 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 269 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 270 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 271 Key Information - Jazz Pharmaceuticals plc
  • TABLE 272 Key Information - Shionogi & Co., Ltd.
  • TABLE 273 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 274 Key Information - Pfizer, Inc.
  • TABLE 275 Key Information - Bioprojet
  • TABLE 276 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 277 Key Information - Ligand Pharmaceuticals, Inc.
  • TABLE 278 Key Information - Graymark Healthcare, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Narcolepsy Therapeutics Market Share by Type, 2021
  • FIG 3 Global Narcolepsy Therapeutics Market Share by Type, 2028
  • FIG 4 Global Narcolepsy Therapeutics Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Narcolepsy Therapeutics Market Share by Product, 2021
  • FIG 6 Global Narcolepsy Therapeutics Market Share by Product, 2028
  • FIG 7 Global Narcolepsy Therapeutics Market by Product, 2018 - 2028, USD Million
  • FIG 8 Global Narcolepsy Therapeutics Market Share by Region, 2021
  • FIG 9 Global Narcolepsy Therapeutics Market Share by Region, 2028
  • FIG 10 Global Narcolepsy Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Jazz Pharmaceuticals PLC